OMED
OncoMed Pharmaceuticals, Inc.
OMED
OMED
Delisted
OMED was delisted on the 22nd of April, 2019.
58 hedge funds and large institutions have $88.1M invested in OncoMed Pharmaceuticals, Inc. in 2017 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 18 increasing their positions, 23 reducing their positions, and 16 closing their positions.
Holders
58
Holders Change
-10
Holders Change %
-14.71%
% of All Funds
1.45%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
18
Reduced
23
Closed
16
Calls
$75K
Puts
$2K
Net Calls
+$73K
Net Calls Change
+$294K
Top Buyers
1 |
PA
1
Perceptive Advisors
New York
|
$4.69M |
2 |
CS
2
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
$1.67M |
3 |
3
D.E. Shaw & Co
New York
|
$714K |
4 |
PP
4
PDT Partners
New York
|
$420K |
5 |
BCM
5
Bridgeway Capital Management
Houston,
Texas
|
$402K |